Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T20:54:09.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The update adds study-center contact information, links to official documents, and IPD data-sharing details to the page, and removes a 403 page placeholder and the Home link.
    Difference
    90%
    Check dated 2026-09-29T20:47:27.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study page for NCT03642132 now displays a 403 Forbidden error, replacing the previous study record content with an access-denied message. As a result, the detailed study information, enrollment data, and location lists are no longer accessible on that page.
    Difference
    18%
    Check dated 2026-09-22T23:00:53.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-09-15T20:55:23.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added the topic 'Ovarian cancer' and a related topics entry 'MedlinePlus Genetics' to categorize the study and guide users to authoritative genetics resources.
    Difference
    0.1%
    Check dated 2026-09-08T20:05:02.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    A new page revision tag, Revision: v3.6.6, was added. Several related-topic items (Ovarian cancer, MedlinePlus Genetics) and the 'related topics' header were removed.
    Difference
    0.1%
    Check dated 2026-09-01T21:53:48.000Z thumbnail image

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.